DECIBEL THERAPEUTICS INC's ticker is DBTX and the CUSIP is 24343R106. A total of 44 filers reported holding DECIBEL THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,003,000 | -81.6% | 330,000 | -71.8% | 0.04% | -70.6% |
| Q4 2021 | $5,441,000 | -39.7% | 1,170,048 | 0.0% | 0.15% | -32.0% |
| Q3 2021 | $9,021,000 | -10.5% | 1,170,048 | -0.1% | 0.22% | -12.1% |
| Q2 2021 | $10,074,000 | -22.6% | 1,171,421 | +2.2% | 0.26% | -34.0% |
| Q1 2021 | $13,023,000 | – | 1,146,421 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,139,685 | $14,600,000 | 3.65% |
| Samsara BioCapital, LLC | 826,422 | $3,843,000 | 0.75% |
| Orbimed Advisors | 4,945,192 | $22,995,000 | 0.30% |
| Alphabet Inc. | 1,636,258 | $7,609,000 | 0.18% |
| Casdin Capital, LLC | 1,170,048 | $5,441,000 | 0.15% |
| HARVARD MANAGEMENT CO INC | 328,798 | $1,529,000 | 0.14% |
| Bronte Capital Management Pty Ltd. | 157,216 | $731,000 | 0.05% |
| ATLAS CAPITAL ADVISORS LLC | 41,025 | $190,766,000 | 0.03% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 263,600 | $1,226,000 | 0.02% |
| Woodline Partners LP | 275,001 | $1,279,000 | 0.02% |